Icagen Relocates Corporate HQ to RTP

Icagen, Inc., a provider of services for ion channel and transporter drug discovery and development, is consolidating its research operations and relocating corporate headquarters to its facility in the Research Triangle Park (RTP) area of NC. The move is scheduled to be complete by the end of December 2015.
 
“In our ongoing efforts to provide the highest quality services to Icagen’s customers, we are bringing together all of our research operations and scientific expertise at our facility in RTP. This allows us to consolidate the wide array of technologies and capabilities that we have to offer, including our XRpro platform, under one roof,” said Richie Cunningham, Icagen president and chief executive officer. “The re-emergence of Icagen has been very well received by the biopharma community to date, and we are already engaged in a number of active research programs including our ongoing collaboration with Pfizer. This move is expected to further enhance our ability to help our customers advance their drug discovery programs in the most efficient manner possible.”